Europe Genome Editing Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology (CRISPR, TALEN, Antisense, and Other), Application (Cell Line Engineering, Genetic Engineering, Diagnostic Applications, Drug Discovery, and Others), and End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Clinical Research Organizations)
Market Introduction
The European genome editing market is divided into Germany, the UK, France, Italy, Spain, and the Rest of Europe. The region holds a significant market share in the Europe genome editing market. Europe occupies a significant position in the Europe genome editing market and is estimated to register a robust growth rate over the forecast period. The market growth in the region is expected due to growing life science research and increase in the investment for research and development.
Countries in the European regions were profoundly affected due to the COVID-19 pandemic. For instance, countries such as Italy, Spain, and France have reported the highest number of positive cases and have registered the maximum number of deaths. The cell therapy instruments supply chain, which is already logistically complicated, has to face new challenges. The cell therapy instrument market has also witness some shortfall at the beginning of COVID 19 crisis owing to factors such as disruption in supply chain and demand due to lock down announced by majority of European countries. For instance, in July 2020 the UK government has allotted 100 million Euros funds to the Cell and Gene Therapy Catapult Manufacturing Innovation Centre to expedite the production of a vaccine for COVID-19 in the UK. Moreover, Stempeutics Research has filed application seeking European Commission Funding to develop cell therapy for COVID 19. The company has also entered into partnership with global consortium of cell therapy companies to gather funding for cell therapy research from European commission. Hence, Europe market is likely to show significant growth prospects during this pandemic and forecasted year.
Market Overview and Dynamics
The genome editing market in Europe is expected to grow US$ 1,487.30 million in 2021 to US$ 4,791.46 million by 2028; it is estimated to grow at a CAGR of 18.2% from 2021 to 2028. Technological developments in healthcare IT allow the use of artificial intelligence (AI) for manufacturing CRISPR Systems. Developers working in the healthcare IT domain are engaged in analyzing the processes to control and monitor all the stages of product development. The focus is to develop technologies from discovering biomarkers to clinical trials and patient monitoring. A few companies have initiated implementing their expertise to use AI for digital manufacturing. In June 2018, Celixir plc acquired Desktop Genetics to develop CRISPR-based gene editing. In August 2018, bluebird bio, Inc. and Gritstone Oncology, Inc. collaborated to develop and commercialize cell therapy products intended for cancer treatment. Under the agreement, Gritstone Oncology has utilized its proprietary EDGE artificial intelligence platform to analyze specific tumor types. EDGE AI platform has helped identify tumor-specific targets and natural T-cell receptors (TCRs) that are used as targets by bluebird bio to develop cell therapies. Further, Gritstone Oncology has utilized those identified targets to conduct development, manufacturing, and commercial processes. Thus, such innovations are expected to foster genome editing and enhance the market growth in the coming years.
Key Market Segments
In term of technological, CRISPR segment held a larger market share of the genome editing market in 2021. In term of application, genetic engineering segment held a larger market share of the genome editing market in 2021. In term of end user, pharmaceutical and biotechnology companies segment held a larger market share of the genome editing market in 2021.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the genome editing market in Europe are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are THERMO FISHER SCIENTIFIC INC.; MERCK KGaA; Lonza; Horizon Discovery Group plc.; Integrated DNA Technologies; GenScript; New England Biolabs; Eurofins Scientific; and CRISPR Therapeutics among others.
Reasons to buy report
- To understand the Europe genome editing market landscape and identify market segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for Europe genome editing market
- Efficiently plan M&A and partnership deals in Europe genome editing market by identifying market segments with the most promising probable sales
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form Europe genome editing market
- Obtain market revenue forecast for market by various segments from 2021-2028 in Europe region.
Europe Genome Editing Market Segmentation
Europe Genome Editing Market – By Technology
- CRISPR
- TALEN
- Antisense
- Other
Europe Genome Editing Market – By Application
- Cell Line Engineering
- Genetic Engineering
- Diagnostic Applications
- Drug Discovery
- Others
Europe Genome Editing Market – By End User
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
- Clinical Research Organizations (CRO's)
Europe Genome Editing Market – By Country
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
Europe Genome Editing Market – Companies Mentioned
- THERMO FISHER SCIENTIFIC INC.
- MERCK KGaA
- Lonza
- Horizon Discovery Group plc.
- Integrated DNA Technologies
- GenScript
- New England Biolabs
- Eurofins Scientific
- CRISPR Therapeutics
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Genome Editing Market– By Technology
1.3.2 Europe Genome Editing Market– By Application
1.3.3 Europe Genome Editing Market– By End User
1.3.4 Europe Genome Editing Market– By Country
2. Europe Genome Editing Market– Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Genome Editing Market– Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Expert Opinion
5. Europe Genome Editing Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Burgeoning Prevalence of Cancer and Other Genetic Disorders
5.1.2 Progressive Technological Advancements in Gene-Editing Tools
5.2 Market Restraints
5.2.1 Expensive Cost of Genomic Equipment
5.3 Future Trends
5.3.1 Growing Technological Innovations
5.4 Impact Analysis
6. Europe Genome Editing Market Analysis
6.1 Europe Genome Editing Market Revenue Forecast and Analysis
7. Europe Genome Editing Market Revenue and Forecasts to 2028– by Technology
7.1 Overview
7.2 Europe Genome Editing Market, By Technology, 2021 & 2028 (%)
7.3 Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)
7.3.1 Overview
7.3.2 CRISPR: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
7.4 TALEN
7.4.1 Overview
7.4.2 TALEN: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
7.5 Antisense
7.5.1 Overview
7.5.2 Antisense: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
8. Europe Genome Editing Market Revenue and Forecasts to 2028 – Application
8.1 Overview
8.2 Europe Genome Editing Market Share, By Application - 2021 & 2028 (%)
8.3 Cell Line Engineering
8.3.1 Overview
8.3.2 Cell Line Engineering: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
8.4 Genetic Engineering
8.4.1 Overview
8.4.2 Genetic Engineering: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
8.5 Diagnostic Applications
8.5.1 Overview
8.5.2 Diagnostic Applications: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
8.6 Drug Discovery
8.6.1 Overview
8.6.2 Drug Discovery: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
9. Europe Genome Editing Market Revenue and Forecasts to 2028 – End User
9.1 Overview
9.2 Europe Genome Editing Market Share by End User - 2021 & 2028 (%)
9.3 Pharmaceutical and Biotechnology Companies
9.3.1 Overview
9.3.2 Pharmaceutical and Biotechnology Companies: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
9.4 Clinical Research Organizations (CRO’s)
9.4.1 Overview
9.4.2 Clinical Research Organizations: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
9.5 Academic and Research Institutes
9.5.1 Overview
9.5.2 Academic and Research Institutes: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
10. Europe Genome Editing Market – Country Analysis
10.1 Overview
10.1.1 Europe: Genome Editing Market, by Country, 2021 & 2028 (%)
10.1.1.1 Germany: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 Germany: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.3 Germany: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.4 Germany: Genome Editing Market, by Applications– Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.5 Germany: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2 France: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 France: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.3 France: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.4 France: Genome Editing Market, by Applications– Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.5 France: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3 UK: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 UK: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.3 UK: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.4 UK: Genome Editing Market, by Applications– Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.5 UK: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.1.1.4 Italy: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.1 Overview
10.1.1.4.2 Italy: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.3 Italy: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.4 Italy: Genome Editing Market, by Applications– Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.5 Italy: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.1.1.5 Spain: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.1 Overview
10.1.1.5.2 Spain: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.3 Spain: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.4 Spain: Genome Editing Market, by Applications– Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.5 Spain: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.1.1.6 Rest of Europe: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.1 Overview
10.1.1.6.2 Rest of Europe: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.3 Rest of Europe: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.4 Rest of Europe: Genome Editing Market, by Applications– Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.5 Rest of Europe: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
11. Impact Of COVID-19 Pandemic on Europe Genome Editing Market
11.1 Europe: Impact Assessment of COVID-19 Pandemic
12. Europe Genome Editing Market– Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. Company Profiles
13.1 THERMO FISHER SCIENTIFIC INC.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 MERCK KGaA
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Lonza
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Horizon Discovery Group plc.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Integrated DNA Technologies
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 GenScript
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 New England Biolabs
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Eurofins Scientific
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 CRISPR Therapeutics
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
14. Appendix
14.1 Glossary of Terms
LIST OF TABLES
Table 1. Germany: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 2. Germany: Genome Editing Market, by Applications– Revenue and Forecast to 2028 (US$ Million)
Table 3. Germany: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 4. France: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 5. France: Genome Editing Market, by Applications– Revenue and Forecast to 2028 (US$ Million)
Table 6. France: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 7. UK: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 8. UK: Genome Editing Market, by Applications– Revenue and Forecast to 2028 (US$ Million)
Table 9. UK: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 10. Italy: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 11. Italy: Genome Editing Market, by Applications– Revenue and Forecast to 2028 (US$ Million)
Table 12. Italy: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 13. Spain: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 14. Spain: Genome Editing Market, by Applications– Revenue and Forecast to 2028 (US$ Million)
Table 15. Spain: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 16. Rest of Europe: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 17. Rest of Europe: Genome Editing Market, by Applications– Revenue and Forecast to 2028 (US$ Million)
Table 18. Rest of Europe: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 19. Organic Developments Done by Companies
Table 20. Inorganic Developments Done by Companies
Table 21. Glossary of Terms, Europe Genome Editing Market
LIST OF FIGURES
Figure 1. Europe Genome Editing Market Segmentation
Figure 2. Europe Genome Editing Market Segmentation, By Country
Figure 3. Europe Genome Editing Market Overview
Figure 4. CRISPR Held Largest Share of Technology Segment in Europe Genome Editing Market
Figure 5. Germany to Show Remarkable Growth During Forecast Period
Figure 6. Europe Genome Editing Market, Industry Landscape
Figure 7. Europe: PEST Analysis
Figure 8. Expert Opinion
Figure 9. Europe Genome Editing Market Impact Analysis of Drivers and Restraints
Figure 10. Europe Genome Editing Market– Revenue Forecast and Analysis – 2021-2028
Figure 11. Europe Genome Editing Market, by Technology, 2021 & 2028 (%)
Figure 12. CRISPR: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
Figure 13. TALEN: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
Figure 14. Antisense: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
Figure 15. Others: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
Figure 16. Europe Genome Editing Market Share, by Application - 2021 & 2028 (%)
Figure 17. Cell Line Engineering: Genome Editing Market Revenue and Forecasts to 2028 (US$ Million)
Figure 18. Genetic Engineering: Genome Editing Market Revenue and Forecasts to 2028 (US$ Million)
Figure 19. Diagnostic Applications: Genome Editing Market Revenue and Forecasts to 2028 (US$ Million)
Figure 20. Drug Discovery: Genome Editing Market Revenue and Forecasts to 2028 (US$ Million)
Figure 21. Others: Genome Editing Market Revenue and Forecasts to 2028 (US$ Million)
Figure 22. Europe Genome Editing Market Share by End User - 2021 & 2028 (%)
Figure 23. Pharmaceutical and Biotechnology Companies: Genome Editing Market Revenue and Forecasts to 2028 (US$ Million)
Figure 24. Clinical Research Organizations: Genome Editing Market Revenue and Forecasts to 2028 (US$ Million)
Figure 25. Academic and Research Institutes: Genome Editing Market Revenue and Forecasts to 2028 (US$ Million)
Figure 26. Europe: Genome Editing Market, by Key Country – Revenue (2021) (US$ Million)
Figure 27. Europe: Genome Editing Market, by Country, 2021 & 2028 (%)
Figure 28. Germany: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. France: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. UK: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Italy: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. Spain: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 33. Rest of Europe: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 34. Impact of COVID-19 Pandemic in European Country Markets
- THERMO FISHER SCIENTIFIC INC.
- MERCK KGaA
- Lonza
- Horizon Discovery Group plc.
- Integrated DNA Technologies
- GenScript
- New England Biolabs
- Eurofins Scientific
- CRISPR Therapeutics
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe genome editing market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the Europe genome editing market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the genome editing market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution